Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Von Eschenbach testifies on ‘08 budget

This article was originally published in The Gray Sheet

Executive Summary

Chairwoman Rosa DeLauro, D-Conn., welcomed increased FDA funding for "accessing additional databases for safety data, hiring more epidemiologists to evaluate these databases and improving the adverse event reporting system," at a Feb. 28 House Agriculture, Rural Development, FDA and Related Agencies Subcommittee hearing on FDA's fiscal 2008 budget request. Testifying before the subcommittee, FDA Commissioner Andrew von Eschenbach discussed the $7.2 million increase request for CDRH, emphasizing postmarket safety activities (1"The Gray Sheet" Feb. 12, 2007, p. 3)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024557

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel